blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2893930

EP2893930 - COMPOUNDS FOR ENHANCING ERYTHROPOIESIS [Right-click to bookmark this link]
Former [2015/29]Compounds for enhancing erythropoiesis
[2019/31]
StatusNo opposition filed within time limit
Status updated on  12.02.2021
Database last updated on 22.08.2024
FormerThe patent has been granted
Status updated on  06.03.2020
FormerGrant of patent is intended
Status updated on  02.07.2019
FormerExamination is in progress
Status updated on  06.10.2017
Most recent event   Tooltip15.07.2022Lapse of the patent in a contracting state
New state(s): BE		published on 17.08.2022  [2022/33]
Applicant(s)For all designated states
Wu, Sophia Shu Fen
426 Park Avenue
Yonkers, NY 10703 / US
For all designated states
Wu, Rong-Tsun
No. 155, Sec. 2 Linong Street
Taipei 112 / TW
[2015/29]
Inventor(s)01 / Wu, Rong-Tsun
No. 155, Sec. 2 Linong Street
112 Taipei / TW
 [2015/29]
Representative(s)Straus, Alexander, et al
2K Patent- und Rechtsanwälte
Bajuwarenring 14
82041 Oberhaching / DE
[N/P]
Former [2020/15]Straus, Alexander, et al
2K Patent- und Rechtsanwälte Dr. Alexander Straus
Keltenring 9
82041 München / Oberhaching / DE
Former [2015/29]Straus, Alexander
Patentanwälte
Becker, Kurig, Straus
Bavariastrasse 7
80336 München / DE
Application number, filing date14176172.621.12.2009
[2015/29]
Priority number, dateUS2008034392224.12.2008         Original published format: US 343922
[2015/29]
Previously filed application, dateWO2009US6895721.12.2009
[2015/29]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2893930
Date:15.07.2015
Language:EN
[2015/29]
Type: A3 Search report 
No.:EP2893930
Date:12.08.2015
[2015/33]
Type: B1 Patent specification 
No.:EP2893930
Date:08.04.2020
Language:EN
[2020/15]
Search report(s)(Supplementary) European search report - dispatched on:EP10.07.2015
ClassificationIPC:A61K31/7034, A61P7/06, A61P13/12, A61P25/00, A61P9/00, A61P9/10, A61P1/16, A61P11/00, A61P1/00, A61P19/08, A61P19/02, A61P21/00, A61P17/00, A61P43/00, A61P37/08, C07H15/203
[2019/29]
CPC:
A61K31/7034 (EP,KR,US); A61P1/00 (EP); A61P1/04 (EP);
A61P1/16 (EP); A61P11/00 (EP); A61P13/12 (EP);
A61P17/00 (EP); A61P17/02 (EP); A61P19/00 (EP);
A61P19/02 (EP); A61P19/08 (EP); A61P21/00 (EP);
A61P25/00 (EP); A61P25/02 (EP); A61P25/28 (EP);
A61P29/00 (EP); A61P3/10 (EP); A61P37/08 (EP);
A61P43/00 (EP); A61P7/00 (EP); A61P7/06 (EP);
A61P9/00 (EP); A61P9/10 (EP); A61P9/14 (EP);
C07H15/203 (EP,US) (-)
Former IPC [2015/33]A61K31/7034, A61P7/06, A61P13/12, A61P25/00, A61P9/00, A61P9/10, A61P1/16, A61P11/00, A61P1/00, A61P19/08, A61P19/02, A61P21/00, A61P17/00, A61P43/00, A61P37/08
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2016/12]
Former [2015/29]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  SM,  TR 
TitleGerman:VERBINDUNGEN ZUR VERSTÄRKUNG DER ERYTHROPOESE[2019/31]
English:COMPOUNDS FOR ENHANCING ERYTHROPOIESIS[2019/31]
French:COMPOSÉS POUR L'AMPLIFICATION DE L'ÉRYTHROPOÏÈSE[2019/31]
Former [2015/29]Verbindungen zur Verstärkung der Erythropoese
Former [2015/29]Compounds for enhancing erythropoiesis
Former [2015/29]Composés pour l'amplification de l'érythropoïèse
Examination procedure12.02.2016Amendment by applicant (claims and/or description)
12.02.2016Examination requested  [2016/12]
06.10.2017Despatch of a communication from the examining division (Time limit: M06)
04.04.2018Reply to a communication from the examining division
31.08.2018Despatch of a communication from the examining division (Time limit: M06)
27.02.2019Reply to a communication from the examining division
03.07.2019Communication of intention to grant the patent
31.10.2019Fee for grant paid
31.10.2019Fee for publishing/printing paid
31.10.2019Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP09775516.9  / EP2381948
Divisional application(s)EP19206081.2  / EP3628321
Opposition(s)12.01.2021No opposition filed within time limit [2021/11]
Fees paidRenewal fee
08.07.2014Renewal fee patent year 03
08.07.2014Renewal fee patent year 04
08.07.2014Renewal fee patent year 05
30.09.2014Renewal fee patent year 06
18.12.2015Renewal fee patent year 07
29.12.2016Renewal fee patent year 08
12.12.2017Renewal fee patent year 09
12.12.2018Renewal fee patent year 10
27.02.2020Renewal fee patent year 11
Penalty fee
Additional fee for renewal fee
31.12.201911   M06   Fee paid on   27.02.2020
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU21.12.2009
AT08.04.2020
CY08.04.2020
CZ08.04.2020
DK08.04.2020
EE08.04.2020
ES08.04.2020
FI08.04.2020
HR08.04.2020
IT08.04.2020
LT08.04.2020
LV08.04.2020
MC08.04.2020
MK08.04.2020
MT08.04.2020
NL08.04.2020
PL08.04.2020
RO08.04.2020
SE08.04.2020
SI08.04.2020
SK08.04.2020
SM08.04.2020
TR08.04.2020
BG08.07.2020
NO08.07.2020
GR09.07.2020
IS08.08.2020
PT17.08.2020
IE21.12.2020
LU21.12.2020
BE31.12.2020
[2022/33]
Former [2022/32]HU21.12.2009
AT08.04.2020
CY08.04.2020
CZ08.04.2020
DK08.04.2020
EE08.04.2020
ES08.04.2020
FI08.04.2020
HR08.04.2020
IT08.04.2020
LT08.04.2020
LV08.04.2020
MC08.04.2020
MK08.04.2020
MT08.04.2020
NL08.04.2020
PL08.04.2020
RO08.04.2020
SE08.04.2020
SI08.04.2020
SK08.04.2020
SM08.04.2020
TR08.04.2020
BG08.07.2020
NO08.07.2020
GR09.07.2020
IS08.08.2020
PT17.08.2020
IE21.12.2020
LU21.12.2020
Former [2022/27]HU21.12.2009
AT08.04.2020
CY08.04.2020
CZ08.04.2020
DK08.04.2020
EE08.04.2020
ES08.04.2020
FI08.04.2020
HR08.04.2020
IT08.04.2020
LT08.04.2020
LV08.04.2020
MC08.04.2020
MT08.04.2020
NL08.04.2020
PL08.04.2020
RO08.04.2020
SE08.04.2020
SI08.04.2020
SK08.04.2020
SM08.04.2020
TR08.04.2020
BG08.07.2020
NO08.07.2020
GR09.07.2020
IS08.08.2020
PT17.08.2020
IE21.12.2020
LU21.12.2020
Former [2021/47]AT08.04.2020
CZ08.04.2020
DK08.04.2020
EE08.04.2020
ES08.04.2020
FI08.04.2020
HR08.04.2020
IT08.04.2020
LT08.04.2020
LV08.04.2020
MC08.04.2020
NL08.04.2020
PL08.04.2020
RO08.04.2020
SE08.04.2020
SI08.04.2020
SK08.04.2020
SM08.04.2020
BG08.07.2020
NO08.07.2020
GR09.07.2020
IS08.08.2020
PT17.08.2020
IE21.12.2020
LU21.12.2020
Former [2021/46]AT08.04.2020
CZ08.04.2020
DK08.04.2020
EE08.04.2020
ES08.04.2020
FI08.04.2020
HR08.04.2020
IT08.04.2020
LT08.04.2020
LV08.04.2020
MC08.04.2020
NL08.04.2020
PL08.04.2020
RO08.04.2020
SE08.04.2020
SI08.04.2020
SK08.04.2020
SM08.04.2020
BG08.07.2020
NO08.07.2020
GR09.07.2020
IS08.08.2020
PT17.08.2020
IE21.12.2020
Former [2021/40]AT08.04.2020
CZ08.04.2020
DK08.04.2020
EE08.04.2020
ES08.04.2020
FI08.04.2020
HR08.04.2020
IT08.04.2020
LT08.04.2020
LV08.04.2020
MC08.04.2020
NL08.04.2020
PL08.04.2020
RO08.04.2020
SE08.04.2020
SI08.04.2020
SK08.04.2020
SM08.04.2020
BG08.07.2020
NO08.07.2020
GR09.07.2020
IS08.08.2020
PT17.08.2020
Former [2021/24]AT08.04.2020
CZ08.04.2020
DK08.04.2020
EE08.04.2020
ES08.04.2020
FI08.04.2020
HR08.04.2020
IT08.04.2020
LT08.04.2020
LV08.04.2020
NL08.04.2020
PL08.04.2020
RO08.04.2020
SE08.04.2020
SI08.04.2020
SK08.04.2020
SM08.04.2020
BG08.07.2020
NO08.07.2020
GR09.07.2020
IS08.08.2020
PT17.08.2020
Former [2021/10]AT08.04.2020
CZ08.04.2020
DK08.04.2020
EE08.04.2020
ES08.04.2020
FI08.04.2020
HR08.04.2020
IT08.04.2020
LT08.04.2020
LV08.04.2020
NL08.04.2020
PL08.04.2020
RO08.04.2020
SE08.04.2020
SK08.04.2020
SM08.04.2020
BG08.07.2020
NO08.07.2020
GR09.07.2020
IS08.08.2020
PT17.08.2020
Former [2021/09]AT08.04.2020
CZ08.04.2020
DK08.04.2020
EE08.04.2020
ES08.04.2020
FI08.04.2020
HR08.04.2020
IT08.04.2020
LT08.04.2020
LV08.04.2020
NL08.04.2020
RO08.04.2020
SE08.04.2020
SM08.04.2020
BG08.07.2020
NO08.07.2020
GR09.07.2020
IS08.08.2020
PT17.08.2020
Former [2021/08]DK08.04.2020
ES08.04.2020
FI08.04.2020
HR08.04.2020
LT08.04.2020
LV08.04.2020
NL08.04.2020
RO08.04.2020
SE08.04.2020
SM08.04.2020
BG08.07.2020
NO08.07.2020
GR09.07.2020
IS08.08.2020
PT17.08.2020
Former [2021/01]FI08.04.2020
HR08.04.2020
LT08.04.2020
LV08.04.2020
NL08.04.2020
SE08.04.2020
BG08.07.2020
NO08.07.2020
GR09.07.2020
IS08.08.2020
PT17.08.2020
Former [2020/50]FI08.04.2020
HR08.04.2020
LT08.04.2020
LV08.04.2020
NL08.04.2020
SE08.04.2020
NO08.07.2020
GR09.07.2020
IS08.08.2020
PT17.08.2020
Former [2020/48]FI08.04.2020
LT08.04.2020
NL08.04.2020
SE08.04.2020
NO08.07.2020
IS08.08.2020
PT17.08.2020
Former [2020/47]LT08.04.2020
NO08.07.2020
IS08.08.2020
Former [2020/46]IS08.08.2020
Documents cited:Search[A]CN1303858  ;
 [X]CN1258520  ;
 [X]CN1404851  ;
 [X]CN1383868  ;
 [X]US2004265397  (WANG GANG [CN], et al) [X] 1-5,7 * paragraphs [0001] , [00 2] * * experiment sample 1;; table 4 * * execution examples 1-4 * * claim 1 *;
 [XD]US2005042314  (WU RONG-TSUN [TW]) [XD] 1-7 * paragraph [0016] - paragraph [0017] * * figures 3, 4; example 3 * * claims 1, 6 *;
 [X]  - KIMURA Y ET AL, "EFFECTS OF STILBENE COMPONENTS OF ROOTS OF POLYGONUM SSP. ON LIVER INJURY IN PEROXIDIZED OIL-FED RATS", PLANTA MEDICA, THIEME VERLAG, DE, (19830101), vol. 49, no. 1, ISSN 0032-0943, pages 51 - 54, XP009030003 [X] 1-6 * the whole document *
 [A]  - ZHANG WEI ET AL, "Treatment with 2,3,4',5-tetrahydroxystilbene-2-O-.beta.-D-glucoside in atherosclerosis in rats", ZHONGGUO YAOKE DAXUE XUEBAO - JOURNAL OF CHINA PHARMACEUTICAL UNIVERSITY, NANJING, CN, (20070101), vol. 38, no. 3, ISSN 1000-5048, pages 261 - 264, XP008119057 [A] 1-7 * abstract *
 [A]  - JIA XIN ET AL, "Neuroprotective effect of tetrahydroxystilbene glucoside on the rat model of Parkinson 's disease", ZHONGGUO XIN YAO ZAZHI - CHINESE NEW DRUGS JOURNAL, GAI-KAN BIANJIBU, BEIJING, CN, (20080101), vol. 17, no. 9, ISSN 1003-3734, pages 748 - 752, XP008119058 [A] 1-7 * abstract *
 [A]  - DATABASE WPI, 0, Derwent World Patents Index, vol. 2001, no. 63, Database accession no. 2001-558353, XP002569662 & CN1303858 A 20010718 (NO 2 MILITARY MEDICAL COLLEGE PLA) [A] 1-7 * abstract *
 [AD]  - WANG ET AL, "Protective effects of 2,3,5,4'-tetrahydroxystilbene-2-O-beta-d-gluco side, an active component of Polygonum multiflorum Thunb, on experimental colitis in mice", EUROPEAN JOURNAL OF PHARMACOLOGY, ELSEVIER BV, NL, (20071025), vol. 578, no. 2-3, ISSN 0014-2999, pages 339 - 348, XP022405039 [AD] 1-7 * abstract * * page 340, column l, paragraph 2 *

DOI:   http://dx.doi.org/10.1016/j.ejphar.2007.09.013
 [A]  - KIMURA Y ET AL, "EFFECTS OF NATURALLY OCCURRING STILBENE GLUCOSIDES FROM MEDICINAL PLANTS AND WINE, ON TUNOUR GROWTH AND LUNG METASTASIS IN LEWIS LUNG CARCINOMA-BEARING MICE", JOURNAL OF PHARMACY AND PHARMACOLOGY, ROYAL PHARMACEUTICAL SOCIETY OF GREAT BRITAIN, GB, (20001001), vol. 10, no. 52, ISSN 0022-3573, pages 1287 - 1295, XP001069866 [A] 1-7 * abstract *

DOI:   http://dx.doi.org/10.1211/0022357001777270
 [T]  - THERESE BÖHM ET AL, "Food-derived peroxidized fatty acids may trigger hepatic inflammation: A novel hypothesis to explain steatohepatitis", JOURNAL OF HEPATOLOGY, (20130901), vol. 59, no. 3, doi:10.1016/j.jhep.2013.06.002, ISSN 0168-8278, pages 563 - 570, XP055177233 [T] 1-6 * abstract * * page 563, column r, paragraph 2 - page 564, column l, paragraph 2 * * page 566, column r, paragraph l - page 567, column r, paragraph 2 *

DOI:   http://dx.doi.org/10.1016/j.jhep.2013.04.025
 [X]  - DATABASE WPI, 0, Derwent World Patents Index, vol. 2000, no. 52, Database accession no. 2000-558878, XP002741556 & CN1258520 A 20000705 (JIANG D) [X] 1-7 * abstract *
 [X]  - DATABASE WPI, 0, Derwent World Patents Index, vol. 2003, no. 50, Database accession no. 2003-524106, XP002741557 & CN1404851 A 20030326 (LU W) [X] 1-5,7 * abstract *
 [X]  - DATABASE WPI, 0, Derwent World Patents Index, vol. 2003, no. 26, Database accession no. 2003-258359, XP002741558 & CN1383868 A 20021211 (ZHANG Y) [X] 1-5,7 * abstract *
 [I]  - ANDRATSCHKE N ET AL, "Preclinical evaluation of erythropoietin administration in a model of radiation-induced kidney dysfunction", INTERNATIONAL JOURNAL OF RADIATION: ONCOLOGY BIOLOGY PHYSICS, PERGAMON PRESS, USA, vol. 64, no. 5, doi:10.1016/J.IJROBP.2005.11.042, ISSN 0360-3016, (20060401), pages 1513 - 1518, (20060401), XP024897844 [I] 1-5,7 * abstract * * page 1516, column l, paragraph 1; figure 3; tables 1, 2 *

DOI:   http://dx.doi.org/10.1016/j.ijrobp.2005.11.042
 [I]  - ARCASOY MURAT O, "The non-haematopoietic biological effects of erythropoietin", BRITISH JOURNAL OF HAEMATOLOGY, BLACKWELL PUBLISHING LTD, (20080401), vol. 141, no. 1, ISSN 1365-2141, pages 14 - 31, XP009154897 [I] 1-5,7 * page 20, column l, paragraph l - column r, paragraph 1 *
 [A]  - TAO YI ET AL, "Identification and determination of the major constituents in traditional Chinese medicinal plantPolygonum multiflorum thunb by HPLC coupled with PAD and ESI/MS", PHYTOCHEMICAL ANALYSIS, (20070501), vol. 18, no. 3, doi:10.1002/pca.963, ISSN 0958-0344, pages 181 - 187, XP055198802 [A] 1-7 * the whole document *

DOI:   http://dx.doi.org/10.1002/pca.963
by applicantUS2005042314
    - ARCASOY MO., BR J HAEMATOL., (2008), vol. 141, pages 14 - 31
    - BUNN HF., BLOOD, (2007), vol. 109, pages 868 - 873
    - CORAZZA F. ET AL., PEDIATR RES., (2004), vol. 55, pages 152 - 158
    - DE KANTER R., TOXICOL IN VITRO, (1999), vol. 13, pages 737 - 744
    - DO AMARAL CL. ET AL., ARCH TOXICOL., (2008), vol. 82, pages 363 - 730
    - ECKARDT KU; KURTZ A., EUR J CLIN INVEST., (1992), vol. 89, pages 753 - 760
    - ECKARDT KU; KURTZ A., EUR J CLIN INVEST., (2005), vol. 35, no. 3, pages 13 - 19
    - FISHER JW., EXP BIOL MED (MAYWOOD)., (2003), vol. 228, pages 1 - 14
    - FUNAKOSHI H; NAKAMURA T., CLIN CHIM ACTA., (2003), vol. 327, pages 1 - 23
    - GUAN S. ET AL., PHYTOTHER RES., (2008), vol. 22, pages 660 - 663
    - HODGES VM., CRIT REV ONCOL HEMATOL., (2007), vol. 64, pages 139 - 158
    - IDO A., J GASTROENTEROL., (2005), vol. 40, pages 925 - 931
    - IGUCHI T., STEM CELLS, (1999), vol. 17, pages 82 - 91
    - ISOBE M. ET AL., TRENDS CARDIOVASC MED., (2006), vol. 16, pages 188 - 193
    - ITO W. ET AL., INT ARCH ALLERGY IMMUNOL., (2008), vol. 146, no. 1, pages 82 - 87
    - JIN M. ET AL., EXP BIOL MED (MAYWOOD, (2003), vol. 228, pages 759 - 766
    - KAIHO S; MIZUNO K., ANAL BIOCHEM., (1985), vol. 149, pages 117 - 120
    - KIMURA Y. ET AL., PLANTA MED., (1983), vol. 49, pages 51 - 54
    - KREAMER BL. ET AL., IN VITRO CELL DEV BIOL., (1986), vol. 22, pages 201 - 211
    - LEVEY AS. ET AL., KIDNEY LNT., (2005), vol. 67, pages 2089 - 3100
    - LIU QL. ET AL., J ASIAN NAT PROD RES., (2007), vol. 9, pages 689 - 697
    - LIU Y., AM J PHYSIOL RENAL PHYSIOL., (2004), vol. 287, pages F7 - 16
    - MATSUMOTO K; NAKAMURA T., KIDNEY INT., (2001), vol. 59, pages 2023 - 2038
    - MIZUNO S; NAKAMURA T., REGEN MED., (2007), vol. 2, pages 161 - 170
    - MORITZ KM. ET AL., AM J PHYSIOL., (1997), vol. 273, pages R1829 - 1844
    - OBATOMI DK ET AL., TOXICOL IN VITRO, (1998), vol. 12, pages 725 - 737
    - ORALLO F., CURR MED CHEM., (2008), vol. 15, pages 1887 - 1898
    - PARRISH AR. ET AL., LIFE SCI., (1995), vol. 57, pages 1887 - 1901
    - PASCHOS N., INT J BIOL SCI., (2008), vol. 4, pages 161 - 168
    - ROSENTHAL A. ET AL., EXP HEMATOL., (1987), vol. 13, pages 174 - 184
    - SEPODES B. ET AL., TRANSPL INT., (2006), vol. 19, pages 919 - 926
    - SHANKAR S. ET AL., FRONT BIOSCI., (2007), vol. 12, pages 4839 - 4854
    - SHARMA S. ET AL., PHARMACOLOGY, (2006), vol. 76, pages 69 - 75
    - TAKEO ET AL., YAKUGAKU ZASSHI, (2007), vol. 127, pages 1813 - 1823
    - WANG R. ET AL., NEUROSCIENCE, (2007), vol. 149, pages 739 - 746
    - WANG X. ET AL., EUR J PHARMACOL., (2008), vol. 578, pages 339 - 348
    - WEISS G; GOODNOUGH LT, N ENGL J MED., (2005), vol. 352, pages 1011 - 1023
    - WISH JB; COYNE DW., MAYO CLIN PROC., (2007), vol. 82, pages 1371 - 1380
    - WORTHINGTON RE., EXP HEMATOL., (1987), vol. 15, pages 85 - 92
    - ZARZECKI M. ET AL., POL ARCH MED WEWN., (2004), vol. 112, pages 1211 - 1219
    - ZHANG YZ ET AL., J ASIAN NAT PROD RES., (2007), vol. 9, pages 355 - 363
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.